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Structural studies of natural product biosynthetic proteins 
Craig A Townsend 
The first high-resolution structures of key proteins involved in the 
biosynthesis of several natural product classes are now appear- 
ing. In some cases, they have resulted in a significantly improved 
mechanistic understanding of the often complex processes 
catalyzed by these enzymes, and they have also opened the way 
for more rational efforts to modify the products made. 
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Introduction 
X-ray qstallography has dramatically advanced our under- 
standing of protein structure and the macromolecular asso- 
ciation of proteins with IlKA, RNA, drugs, cofactors and 
other proteins. Progress has, however, been considerably 
slower in obtaining detailed insights into the enzymes that 
catalyze natural product biosynthesis. ‘I’he reasons for this 
are several; in particular the enzymes concerned have 
modest, even poor, kinetic properties, they are available in 
only minute amounts from wild-type organisms and they 
are often not very stable. As a consequence, they have 
proved difficult to detect, isolate and purify. Efforts towards 
this end have been successful in the last decade, ho\vever, 
and now a number of genes encoding synthetic enzymes for 
natural products of interest have been cloned and recombi- 
nant enzymes have been made available for thorough char- 
acterization. Given the commercial importance of natural 
products, the associated enzymes hai,e become targets for 
manipulation by chemical modification, muragenesis and 
combinatorial methods, not onI\; to improve the production 
of these high-value materials but also, through deeper 
mechanistic understanding, to achieve the efficient synthe- 
sis of new chemical entities. It is axiomatic that both 
dynamic and structural information are required in order to 
understand the behavior of a chemical system. Rioorganic 
chemists (or chemical biologists!) have proved resourceful, 
even ingenious, in devising experiments to relcal in 
exquisite mechanistic detail the frequently complex cat- 
alytic cycles of biosynthetic enzymes. On the other hand, 
high-resolution structures of these proteins, which would be 
immensely useful guides to any program of protein modifi- 
cation for mechanistic or biotechnological ends, ha\,e not 
been available until very recently. Among the first of a 
growing wave of these structures is that of isopenicillin N 0 
synthase at 1.3 A resolution [l], which underscores this 
broader development and prompts this short review. 
Penicillin 
The biosynthesis of penicillin from a tripeptide by a single 
enzyme, isopenicillin N synthase (IPNS), is among the 
most impressive transformations known in natural prod- 
ucts chemistry. In the reaction, a monomeric protein con- 
taining a single ferrous ion, in the presence of one 
molecule of dioxygen, mediates a stcpwise double oxida- 
tive cyclization of &(I,-aminoadipyl)-I,-cysteinyl-r>-valinc 
(ACV, 1) to isopenicillin N (2) and two molecules of water 
(Figure 1) [2,3]. The intermediate I,.r,,r)-tripeptide is in 
turn synthesized from its constituent [,-amino acids and 
ATP by ACV synthetase (AC\%), a member of the wider 
class of nonribosomal peptide synthetases responsible for 
the analogous synthesis of modified polypeptides such as 
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Figure 1 
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The biosynthesis of isopenicillin (2) from its 
primary amino acid precursors. The reaction 
proceeds via an intermediate tripeptide, ACV 
(1). ACVS, ACV synthetase; IPNS, 
isopenicillin N synthase. 
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gramicidin and cyclosporin [4,.5]. Thus, in only two 
cnzymic steps, a compound of enormous value to human 
health is produced by chemical reactions that have an effi- 
ciency unmatched by contemporary synthetic organic 
methods and at a lower cost than that of the primar) 
amino acid building blocks. 
‘I’he X-ray crystal structure of IPNS has recently been 
obtained under anaerobic conditions, in the presence of 
Fe(II) and AC\’ [I]. An earlier crystal structure of the cat- 
alytically inactive hln(II) enzyme showed the metal ion to 
be octahedrally coordinated by HisZ14, Asp216, His270. 
Gln330 and two water molecules [6]. This ligand geometry 
was thought to represent the resting state of the enzyme. 
Notably, when ACV mas bound to the native ferrous 
enzyme, the cysteine thiolate was found to displace the 
glutamine residue and the loss of a water molecule resulted 
in a coordination change to square pyramidal. Yet when 
nitric oxide, a surrogate for dioxygcn, was bound to the 
native enzyme, the ligation geometry returned to octahe- 
dral, the conformation that is believed to represent the cat- 
alytically active enzyme complex, as Teas suggested by 
earlier electron paramagnetic resonance (EPR) and other 
spectroscopic studies [7,8]. Interestingly, in both of the 
latter X-ray structures, the valinc P-hydrogen, Tnhich is 
abstracted late in the catalytic cycle, is directed away from 
the iron center, perhaps contributing to the selectivity of 
the early steps. This intimate view has led to new revisions 
of the proposed mechanism of IPNS [l]. The critical diff- 
culty in any such proposal is to account for the formation of 
two rings, which necessitates the removal of four hydrogen 
atoms and the reduction of a molecule of dioxygen to two 
molecules of water. ‘I‘he essential features of the newI) 
proposed catalytic cycle are outlined in Figure 2. 
. 
In the light of the crystal structure, a series of chemically 
interesting steps has been proposed for isopenicillin K for- 
mation. In the first ring-forming sequence, dioxygen binds 
in trtrns to Asp216 to generate octahedral ferric superoxidc 
3 (Figure 2). A radicaloid oxygen (pcroxy-like) from 3 
abstracts the cysteine P-hydrogen to give the ferrous 
hydroperoxide 4 and the electronic equi\ alcnt of an iron- 
ligated thioaldchyde. Generation of the fcrryl species 
appearing in 5 is invoked to release a hydroxide ion in the 
active site where deprotonation of the amide sets the stage 
for transannular closure to the monocyclic p-lactam 5. For- 
mation of the thiazolidine ring follous suggestions made 
previousI>, [9] that the ferry1 species 5 carries out 
homolytic GH bond cleavage at the valyl P-carbon, prc- 
sumably no\v rotated to correctly position this hydrogen so 
as to initiate formation of the second ring - a process 
indirectly supported by studies of other non-heme [iron] 
oxygenases such as clavaminate synthase (although thcb- 
arc dependent on a-ketoglutarate to activate oxygen) 
[l&-12]. The <is relationship between the A<%’ sulfur 
atom and the reacting iron-oxygen species is critical to 
these oxidativc cyclization processes [13-151. 
The synthesis of the tripeptide ACV and other 
non-ribosomal peptides 
Although the sequential oxidative cyclizations carried out 
by IPNS are the virtuoso performance of a single active 
site, the assembly of its tripeptide substrate, ACL’, 
involves the orchestration of many individual chemical 
steps. A single protein contains the three modular syn- 
thetasc units that are required for the different steps; the 
units select, activate, modify (as necessary) and condense 
three amino acids in an order directed by the organization 
of the full-enzyme structure [4,5,16]. In contrast to IPNS 
(-35 kDa), ACL’S (405-425 kDa) and other non-ribosomal 
peptide synthetascs (NRPSs; Figure 3) are very large 
multifunctional enzymes. For example, gramicidin syn- 
thetase is composed of two separately encoded proteins of 
five modules in total (SW kDa altogether) that catalyze the 
assembly and head-to-tail dimerization of a pentapeptide 
to a cyclic decapeptidc product. Cyclosporin synthetase is 
a single giant protein of molecular mass 1700 kDa and a 
total of 11 modules that combine and Kmethylate natural 
and unnatural amino acids [4,.5,17]. 
Contained within each of the modules of the NRPSs arc 
the first two or more of the following catalytic domains. 
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Figure 2 
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the functions of which have been assigned on the basis of 
biochemical studies and high le~rcls of sequence identity. 
I)etailcd sequence comparisons have Icd to the definition 
of domains responsible for: (1) amino acid recognition and 
adcnylation by ATP, (2) thioestcrification of the resulting 
mixed anhydrides by phosphopantetheine units bound at 
highly conserved scrinc residues, (3) occasional epimcriza- 
tion and/or N-methylation, (1) amide bond formation 
(condensation) and, finally. (5) intramolecular cwlization 
or hydrolvsis bv carboxy-terminal thioesterase domains, as 
Figure 3 
is the case with XC\7S. to release the fully elaborated 
peptidc. The reactions of a single module are depicted in 
Figure 4. Type I NKPSs comprise about 1000 amino 
acids. N-hletkylation domains, which distinguish type II 
from type I NKFYS enzymes, are appro\;iniately 400 amino 
acids long and arc located in the carboxy-terminal region 
of adenylation domains [5]. 
@a .300 precursor molecules are found in non-ribosomal 
polypcptides. ‘I’he ability to assemble these units in 2 
The modular arrangement of some non- 
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Figure 4 
Type I NRPS 1 
The domain organization of a generic type I 
NRPS module and an illustration of the 
120 kDa/Module 
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thiotemplate mechanism of polypeptide 
synthesis. Activation of an amino acid occurs 
by recognition and adenylation followed by 
transfer to the module-bound 
0 0 
f0 
phosphopantetheine. Epimerization (‘Epim’ 
domain) and N-methylation can take place at 
this stage followed, finally, by condensation to 
afford the polypeptide product. Type II NRPS 
enzymes are distinguished by an 
N-methylation domain (orange) in addition to 
those present in a type I system. The module 
with the product bound to 
phosphopantetheine is shown in the box. 
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predetermined order and number by combining the appro- 
priate modules to encode a chimeric synthetase has clear 
mechanistic and practical attractions. In particular, it could 
be imagined that combinatorial methods could be applied 
to the synthesis of new chemical species. Indeed, experi- 
ments have been carried out to show the feasibility of such 
a goal [18]. The X-ray structure of an entire module would 
be of great value for determining the three-dimensional 
relationships between its several catalytic domains, and an 
important advance toward this goal has just been reported 0 
in the 1.9 A structure of the phenylalanine-activating 
subunit of gramicidin synthetase (PheA) [17,19]. Adenyla- 
tion domains play a central role in peptide formation by 
selecting and activating specific building blocks for syn- 
thesis. Nine well-conserved signature sequences have 
been identified within adenylation domains and they are 
believed to be involved in ATP and amino acid binding 
and catalysis [4]. These assignments have been supported 
by mutagenesis studies. The PheA model structure con- 
sists of 512 residues which is in good agreement with the 
size of an entire adenylation domain with both phenylala- 
nine and AMP bound to it. The structure reveals several 
invariant or highly conserved residues within the signature 
motifs that are thought to be involved in AMP binding or 
the interaction of the enzyme with the a-amino and a-car- 
boxy1 of the substrate phenylalanine. Although proteins 
with this level of sequence identity are expected to have 
highly similar main chain conformations, the’ determinants 
of amino acid binding specificity are governed by the 
nature of the protein residues lining the substrate-binding 
pocket. As would be anticipated, differences in these 
regions are evident in individual adenylation domains. 
The model polypeptide folds into two compact sub- 
domains; a large amino-terminal portion that contributes 
most substrate contacts and a significantly smaller carboxy- 
terminal part. Although it shares only 16% amino acid iden- 
tity, principally in short, highly conserved motifs, the X-ray 
crystal structure of unligated firefly luciferase shows 
remarkable topological similarity to the PheA model struc- 
ture [ZO]. One would expect that all adenylation domains, 
which have 30-60% sequence identity, have very similar 
three-dimensional structures. Interestingly, in the model 
PheA structure, the small carboxy-terminal domain is 
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Figure 5 
A linear domainal representation of an animal 
fatty acid synthase. KS, P-ketoacyl synthase; 
AT, acyl transferase (acetyl and malonyl); DH, 
dehydratase; ER, enoyl reductase; KR, 
P-ketoacyl reductase; ACP, acyl carrier 
protein; TE, thioesterase. The relative sizes of 
the domains and the DH-ER linker are 
approximately to scale. 
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rotated approximately 90” relative to its orientation in firefly 
luciferase. Although the model PheA structure includes 
substrate and AMP, the luciferase structure does not. These 
conformational differences may reflect distinct points in the 
catalytic cycles of these proteins-an important dynamic 
consideration to any attempt at protein engineering. 
Modular polyketide synthases 
Another major group of multidomainal biosynthetic pro- 
teins that has achieved prominence recently is the modular 
bacterial polyketide synthases (PKSs), responsible for the 
biosynthesis of, for example, erythromycin [Zl-243 and 
rapamycin [25]. Interestingly, both the primary sequences 
and the organization of individual catalytic domains in 
PKSs closely mimic vertebrate fatty acid synthases (FASs). 
Animal FASs are highly evolved polyproteins (Type I) that 
contain seven catalytic sites: P-ketoacyl synthase (KS), acyl 
transferase (AT), de’hydratase (DH), enoyl reductase (ER), 
p-ketoreductase (KR), acyl carrier protein (ACP) and 
thioesterase (TE) arranged in that order from the amino 
terminus to the carboxy terminus of the protein (Figure 5). 
The active form of the protein exists as a head-to-tail 
homodimer (a,) in which the penultimate ACP domains, 
each with its bound phosphopantetheine arm (Figure 5; 
l = SH), ‘carry’ the intermediates of synthesis through suc- 
cessive rounds of two-carbon extension (homologation) by 
decarboxylative Claisen additions of malonyl-ACP, fol- 
lowed by reduction/dehydration/reduction steps until a 
chain length of C,, or C,, is reached. At this point the acyl- 
pantetheinate of ACP is hydrolyzed at the thioesterase and 
released as the free acid. The whole process is shown 
schematically in Figure 6. 
The two central features of the process are that the active 
sites are used iteratively and that synthesis requires the 
cooperation of catalytic centers located on both of the 
antiparallel subunits [26,27]. Clever complementation 
experiments by Stuart Smith’s group [28,29] have estab- 
lished that a single catalytic complex consists of the 
DH-ER-KR-ACP-TE of one strand and the AT-KS of 
the other, despite the occurrence of a -600 residue linker 
separating the DH and ER domains (Figure 5). The sub- 
units of FAS therefore cannot be positioned in a strictly 
extended, side-by-side manner as was suggested earlier by 
the analysis of electron microscope (EM) images [30,31], 
but must be coiled in some manner to accommodate the 
physical constraints to catalysis that are imposed by the 
length of the phosphopantetheine arm. 
In contrast to vertebrate fatty acid biosynthesis in which 
acetyl-CoA (Figure 6, R = II) and malonyl-CoA (Figure 6, 
R’ = H) cycle through FAS in a repeated manner, micro- 
bial polyketide synthesis extends these basic chemical 
reactions dramatically, especially in bacteria. Starter units 
arc variable (Figure 6, R = H, CH,, ethyl, butyl, isobutyl, 
alkyl. arylalkyl, etc.), and homologations by substituted 
malonyl units are common (Figure 6, R’ = H. CH;. ethyl, 
butyl, etc.). Similarly, reductive transformations that 
proceed in lock step at the P-carbon in fatty acid synthesis 
can stop at any step and homologation can continue. 
hloreover, the P-hydroxyl intermediate can, in principle, 
exist in any of four possible stereochemical configurations 
(Figure 6, “) at the a and p carbons. 
It can be readily appreciated that compounds of great 
SmCtUrdl diversity can be rapidly assembled using the 
simple synthetic reactions available to PKSs. How Nature 
has done this is perhaps best understood through investi- 
gations of the modular PKS of 6-deoxycrythronolide B (6- 
dEB; 6; Figure 7) biosynthesis in S~~~ar~~o~~~.sp~ru 
e~thmetr. In this organism, three large open reading 
frames were discovered that encode three large proteins, 
DEBS l-DEBS 3 [Zl-241. Assignments of individual cat- 
alytic domains were readily made on the basis of their 
high sequence homology to equivalent domains in animal 
FAS. In keeping with a ‘processive’ model of polyketide 
biosynthesis, six modules could be assigned that corre- 
sponded to the initial loading of a propionate starter unit 
and five chain extensions of (ZS)-methylmalonyl-CoA 
1321 and accompanying modifications (Figure 7). In con- 
trast to animal FASs, modular PKSs are elaborately con- 
structed such that each active site is used non-itcrativel) 
(if at all) [2.5]. A telling early experiment both supported 
the validity of the multifunctional catalytic roles proposed 
for the DEBS proteins and raised unmistakably the possi- 
bility of engineering these proteins in a rational \vay for 
the production of new ‘natural’ products. Katz and his 
coworkers at Abbott Laboratories [Z] generated a mutant 
of DKBS 3 in which the ketoreductasc in module 5 (KR; 
Figure 7) was disrupted. The mutant produced an analog 
(7) of 6-dEB bearing a keto group at C-S rather than a 
hydroxyl group as had been hoped. 
726 Chemistry & Biology 1997, Vol 4 No 10 
Figure 6 
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7 A comparison of FAS homologation of acetyl- 
CoA with malonyl-CoA (and their substituted 
derivatives with different groups at R and R’) 
with a generic PKS that shows a varying extent 
of reduction/dehydration/reduction at the 
thloacyl P-carbon prior to further homologation 
(highlighted in color). Both R- and 
S-configurations are possible at the positions 
marked (*). Abbreviations as for Figure 5. 
Erythromycin is a front-lint antibiotic and the commercial remarkable strides are currently being made to exploit the 
importance of other polyketide metabolites is also well biotechnologicai possibilities of the PKSs [36-M]. Similarly, 
appreciated [33-X5]. Lsing the 6-dEB system, in particular, massive up-regulation of human FAS has been associated 
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The modular organization of 
6-deoxyerythronolide B synthase (DEBS) and 
the proposed build up of 6-deoxyerythomycin 
B (6, 6-dEB) in a processive fashion from the 
initiation of synthesis at module 1 to final 
macrocyclization occurring at the 
thioesterase domain of module 6. Other 
abbreviations as for Figure 5. 
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with cancer inter din of the breast, ovary and prostate [39]. 
Detailed tertiary and quarternary information about these 
proteins would be very useful to guide the design of drugs 
targeted to human FAS and to allow selective domainal 
modifications or combinatorial methods of de no~o domain 
assembly in PKSs. The methods that have been applied to 
modular PKS structures have followed those that were used 
earlier for FAS. The Leadlay and Staunton groups [40,41] 
have examined the behavior of the DEBS proteins during 
gel filtration and analytical ultracentrifugation and found 
them, like vertebrate FAS. to be homodimers. Cross- 
linking and partial proteolysis studies clearly indicate a 
structural motif in which the inter-subunit arrangement is 
overall a par&l rather than an anti-parallel arrangement 
[40,41]. But, just as the extended, side-by-side cylinders 
view of animal FAS is now seen as oversimplified [29], so 
must the PKS subunits be intertwined to achieve synthesis. 
Experiments by the Khosla and Cane groups [42] suggest 
.that, like Type I FASs, the ACP on one chain must cooper- 
ate with the KS on the partner chain. ‘They go on to propose 
a dimer model in which the individual modules of one 
chain zig-zag back and forth in one plane and are arrayed 
with their partner in such a way that each module pair is ori- 
ented head-to-tail [42]. In contrast, Leadlav and Staunton 
[41] have advanced a ‘double helical’ model in which the 
chains are twisted together in a parallel head-to-head, tail- 
to-tail fashion; this model can also account for the new 
results of Smith for the Type I FAS [ZC,]. 
Electron microscopy, physical measurements, cross- 
linking and proteolysis experiments have provided low- 
resolution views of FAS [30,31] and, to a lesser extent, of 
the PKS enzymes [40-U]. Closely related to the studies 
described above have been those carried out with the 
fungal Type I PKS h-methylsalicylic acid synthase [43] 
and the first, seminal experiments in this area by Lynen 
[44] on yeast FAS two decades ago. [infortunately, high 
resolution information about Type I systems from X-ray 
crystattography or nuclear magnetic resonance (NhIK) 
spectroscopy is lacking. In bacteria, however, most fatty 
acid biosynthesis is carried out by particulate enzymes 
that have singie active sites (Type II FASs). Some bacter- 
ial PKSs arc particulate as well, such as those involved in 
the synthesis of actinorhodin [33] and tetracenomycin 
[35]. These bacterial enzymes are smaller, more tractable 
targets for detailed structural analysis and have started to 
become a focus for experimental effort. They are also sig- 
nificantly homologous to individual domains of their Type 
I FAS and PKS brethren and, hence, their structures are 
likely to be broadly representative of the corresponding 
domains of these multifunctional proteins. 
The first advance in the structural analysis of the bacterial 
enzymes was reported by Kim and Prestegard [45,46] with 
the solution structure of /zolo-ACP from the Type II FAS 
of Escherichiu co/i. In an important correlation with Type II 
PKSs, Simpson and coworkers [47] have recently 
described a high-resolution NhlK structure of the upo- 
ACP of actinorhodin (crct) synthesis from S~eptom~~.s roeli- 
color, nuclear Overhauser enhancement spectroscopy 
(NOESY) experiments suggest that there is little interac- 
tion between phosphopantetheine and ACP. The tertiary 
folds of the two proteins show strong structural homology, 
despite the generally observed failure of FAS ACPs to 
substitute for PKS ACPs in genetically enginecrcd 
systems. Both ACPs share a hydrophobic core that pre- 
sumably accommodates the growing acyl chain as synthe- 
sis proceeds. It is quite flexible, and differing extents of 
mobility, and different charged and hydrophilic residues 
lie buried within this core. These dynamic and structural 
differences may account for the synthetic discrimination 
shown by the different ACPs [47]. 
X-ray structures of two further proteins of the E. di FAS 
apparatus have been determined recently. The acyl trans- 
ferase that transfers malonate from CoA to ACP has been 0 
crystallized to afford a structure at 15 A [48]. The catalytic 
Ser92 is revealed as hydrogen bonded to a histidine, 
His201, which is typical of hydrolases. but the catalytic 
triad appears to be completed by Gln2.50 rather than the 
usual carboxylic acid of aspartate or glutamate. The 
enzyme is known to be highly discriminating for malonyl- 
CoA in preference to acetyl-CoA, but the origin of this sub- 
strate specificity is not fully clear from the X-ray structure, 
although a nearby arginine may be involved. Enoyl rcduc- 
tase catalyzes the last reaction in the catalytic cycle of FAS 
and requires NADPH (Figure 6); the E. cvli enzyme has 
been crystallized in the presence of NAL)+ and its &ucturc 0 
solved at 2.1 A [49]. Although the NAD’ cofactor presuni- 
ably occupies the expected binding site, the location of the 
&P-unsaturated thioester substrate is not known. 
Terpenes 
The terpenes are the final class of natural products in 
which X-ray crystallography has begun to provide funda- 
mental mechanistic insights. hlore than 23,000 terpenes 
arc known of the widest structural variety of any knobvn 
class of natural product; they range from being essential 
membrane components, steroid hormones and insecticides 
to carotenoids, flavors and fragrances. Central to the for- 
mation of all of these products arc the prenyl transferases 
in which dimethylallyl diphosphate (8; DMAPP; Figure 8) 
and isopentyl diphosphate (9: IPP), the basic building 
blocks of isoprenoids, are condensed to give geranyl 
diphosphate (10; GPP) and inorganic pyrophosphate. In 
an analogous reaction, IPP can react again with this allylic 
diphosphate intermediate to afford farnesyl diphosphate 
(11; FPP) and so forth (Figure 8). 
Avian FPP synthase has been crystallized as a dimer and its 
structure has been determined at 2.6 w resolution [SO]. 
The structure is highly a-helical: each subunit is composed 
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Figure 8 
The assembly of linear isoprenoids by prenyl 
transferase enzymes. 
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of ten core helices surrounding a large central cavity con- 
taining the putative active site. Highly conserved residues 
line this site: notably two Asp-Asp-X-X-Asp motifs, 
which reside on opposing walls of the cavity, as well as spe- 
cific arginine residues. The roles of these amino acids in 
substrate binding and catalysis have been demonstrated by 
site-specific mutagenesis experiments. Mg(II)-IPP has 
been co-crystallized with the prenyl transferase but, unfor- 
tunately, was insufficiently resolved to allow its precise 
placement within the active site. Although the mechanism 
of fundamental chain elongation reactions has been 
studied in detail, a further understanding of the process on 
the basis of the FPP synthase structure has been largely 
elusive, apart from the organization of conserved amino 
acids in the active site. 
The central issue of the control of chain length during the 
prenyl transferase reaction has been addressed in an 
acutely rational manner [Sl]. An examination of the X-ray 
structure of FPP synthase and comparisons among 35 
protein sequences of GPP and FPP synthases and higher 
chain-length synthases points to the potentially important 
roles of a pair of phenylalanine residues that form a ‘floor’ 
to the presumed allylic substrate-binding pocket. In con- 
trast, higher chain-length synthases have smaller or more 
flexible sidechain residues, such as serine, and alanine or 
methioninc, at these sites. Mutants of the avian FPP syn- 
thase bearing alanine and/or serine substitutions at these 
aromatic amino acid sites were constructed and their reac- 
tions were compared with those of the wild-type enzyme 
[Sl]. A single amino acid replacement, Phell2+AlallZ, 
extended the chain length cleanly by one isoprene 
unit to C,,,. Substitution of both aryl groups in the 
Phel lZ+Alal lZ/Phel13~Serll3 double mutant, on the 
other hand, dramatically affected the products formed. A 
distribution of C2o-C7o isoprenoids resulted, with the 
peak at C&Z,,,. The ape-enzyme and structures contain- 
ing GPP and FPP could be obtained, plainly showing 
binding of the allylic diphosphate substrates and a pair of 
Mg(I1) ions at one of the Asp-Asp-X-X-Asp sites with 
their hydrocarbon tails extending toward the mutated 
residues constituting the altered floor of the active site. 
Although longer chain allylic diphosphates could not he 
co-cystallized, molecular modeling exercises disclosed that 
the rotation of just two sidechains opened a passageway 
that was lined mainly with hydrophobic residues. This 
molecular picture provides the sharpest insight into how 
prenyl transferases catalyze the fundamental elongation of 
C, units and control their length. This view of terpene 
biosynthesis will be widened by the X-ray structures of 
three terpene cyclases that are soon to he published (these 
structures have been published whilst this review was in 
press [S&54]). The terpene cyclases take the reaction 
products of prenyl transferases, like FPP synthase, and 
catalyze the formation of the familiar cyclic structural 
types that are characteristic of this natural product class. 
Conclusions 
At the heart of mechanistic enzymology lies a central 
interest in catalysis - how do enzymes achieve their 
extraordinary rate accelerations? As a rule, the enzymes of 
natural product biosynthesis are not so impressive for their 
rates of synthesis hut rather for the reactions that they cat- 
alyze. For natural product enzymes, investigations tend to 
be skewed towards determining the mechanism and its 
relationship to gross structure, as well as to the pragmatic 
considerations of how that knowledge can be applied. The 
point I wish to make is that a threshold has been crossed 
in the study of natural product biosynthetic enzymes that, 
while the inevitable consequence of hard-won advances in 
protein purification and molecular biology, has elevated 
the level of mechanistic discussion to include detailed 
three-dimensional information about protein structure. 
Caveats to interpreting site-specifically mutated enzyme 
behavior to correspond to that of wild-type enzymes 
remain as they were when pointed out a decade ago [SS], 
and limitations can he seen for cases in which substrates 
and/or cofactors cannot he co-crystallized or successfully 
Review Structural studies of natural product biosynthetic proteins Townsend 729 
diffused into presumed active sites. Less obvious is the 
fact that the catalyzed reactions are multistep and 
inescapably involve multiple transition states. The effects 
of protein structural changes, or indeed substrate struc- 
tural changes, on the relative energies of these states (and 
on overall reaction rates and mechanism) will be difficult 
to assess or predict. Linked to this conundrum is the prob- 
able conformational plasticiq of active sites that direct 
reactions through multiple intermediates to one or a 
number of products. IPNS, clavaminate synthase [M] or 
the terpcne cyclases may be broadly cited as examples. An 
X-ray crystal structure affords a snapshot and does not in 
itself give a picture of whatever dynamic flexibility may 
be required to guide all phases of these catalytic events. 
Nonetheless, it is clear that altered substrate specificities 
will be achieved (greatly aided by the availability of high- 
resolution protein structures) and multidomain proteins 
will be created that synthesize new ‘natural’ products. 
These are exciting prospects. It is important to note that 
gi\-en the synthetic capability of natural product enzymes, 
only a small subset of possible structures exists (or has yet 
been discovered). Although the absence of some theoreti- 
cally possible products ma); be a result of unfavorable 
thermodynamics, other selective pressures must be at 
work in Kature as well. It will be interesting to see if. for 
example, the antibiotic properties of the macrolide class of 
natural products can be improved beyond the outcome of 
these forces. 
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